Boldface type indicates significant differences found between intervention and control groups.
RCT indicates randomize controlled trial; PC, palliative care; NSCLC, non-small cell lung cancer; FACT-L, Functional Assessment of Cancer Therapy-Lung, LCS, Lung Cancer Subscale; TOI, Trial Outcome Index; GI, gastrointestinal; GU, genitourinary; FACIT-Sp, Functional Assessment of Chronic Illness Therapy-Spiritual Well Being; QUAL-E, Quality of Life at the End of Life; CES-D, Center for Epidemiologic Studies-Depression; ESAS, Edmonton Symptom Assessment System; CARES-MIS, Cancer Rehabilitation Evaluation System Medical Interaction Subscale; HADS-D, Hospital Anxiety and Depression Scale Depression Subscale; HADS-A, Hospital Anxiety and Depression Scale Anxiety Subscale; PHQ-9, Patient Health Questionnaire 9; EORTC QLQ-C30, European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire- Core 30; FACIT-Pal, Functional Assessment of Chronic Illness Therapy-Palliative Care; CQOL-C, Caregiver QOL Scale-Cancer (CQOL-C); MBCB-OB, Montgomery-Borgatta Caregiver Burden Scale, Overall Burden subscale; MBCB-SB, Montgomery-Borgatta Caregiver Burden, Stress Burden subscale; and MBCB-DB; Montgomery-Borgatta Caregiver Burden, Depression Burden subscale.